Turning Point Therapeutics Inc. (TPTX) NASDAQ

$76.01 0 (0.00%)

Market Cap: $0

As of 08/16/22 12:00 AM EDT. Market closed.

(TPTX)

Turning Point Therapeutics Inc. (TPTX) NASDAQ

$76.01 0 (0.00%)

Market Cap: $0

As of 08/16/22 12:00 AM EDT. Market closed.

Turning Point Therapeutics is a clinical-stage precision oncology company with a pipeline of internally discovered investigational drugs designed to address key limitations of existing cancer therapies. The company's lead drug candidate, repotrectinib, is a next-generation kinase inhibitor targeting the ROS1 and TRK oncogenic drivers of non-small cell lung cancer and advanced solid tumors. ... read more

Turning Point Therapeutics is a clinical-stage precision oncology company with a pipeline of internally discovered investigational drugs designed to address key limitations of existing cancer therapies. The company's lead drug candidate, repotrectinib, is a next-generation kinase inhibitor targeting the ROS1 and TRK oncogenic drivers of non-small cell lung cancer and advanced solid tumors. Repotrectinib, which is being studied in a registrational Phase 2 study in adults and a Phase 1/2 study in pediatric patients, has shown antitumor activity and durable responses among kinase inhibitor treatment-naïve and pre-treated patients. The company's pipeline of drug candidates also includes TPX-0022, targeting MET, CSF1R and SRC, which is being studied in a Phase 1 trial of patients with advanced or metastatic solid tumors harboring genetic alterations in MET; TPX-0046, targeting RET, which is being studied in a Phase 1/2 trial of patients with advanced or metastatic solid tumors harboring genetic alterations in RET; and TPX-0131, a next-generation ALK inhibitor currently pending IND submission. Turning Point's next-generation kinase inhibitors are designed to bind to their targets with greater precision and affinity than existing therapies, with a novel, compact structure that has demonstrated an ability to potentially overcome treatment resistance common with other kinase inhibitors. The company is driven to develop therapies that mark a turning point for patients in their cancer treatment. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO Compensation (Base)
$329,442
CEO Compensation (Total)
$8.66M
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
142
CEO Compensation (Base)
$329,442
CEO Compensation (Total)
$8.66M
Address
.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$0
Previous Close
$76.01
Days Range
$75.98 - $76.01
52 week range
$0 - $0
Volume
0
Avg. Volume (30 days)
0
Market Cap
$0
Dividend Yield
0.00%
P/E
-
Shares Outstanding
50,074,277
Open
$0
Previous Close
$76.01
Days Range
$75.98 - $76.01
52 week range
$0 - $0
Volume
0
Avg. Volume (30 days)
0
Market Cap
$0
Dividend Yield
0.00%
P/E
-
Shares Outstanding
50,074,277

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR TURNING POINT THERAPEUTICS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
George Simeon Director Aug 17, 2022 Option Exercise $76.00 2,253,660 171,278,160 0 Aug 17, 2022, 04:40 PM
Alles Mark J Director Aug 17, 2022 Option Exercise $76.00 2,000 152,000 0 Aug 17, 2022, 04:32 PM
TOMBESI PAOLO EVP & Chief Financial Officer Aug 17, 2022 Option Exercise $76.00 29,778 2,263,128 0 Aug 17, 2022, 04:31 PM
Hirmand Mohammad EVP and Chief Medical Officer Aug 17, 2022 Option Exercise $76.00 41,284 3,137,584 0 Aug 17, 2022, 04:26 PM
Countouriotis Athena President & CEO Aug 17, 2022 Option Exercise $76.00 110,959 8,432,884 0 Aug 17, 2022, 04:23 PM
TOMBESI PAOLO EVP & Chief Financial Officer Jul 27, 2022 Sale $74.94 1,183 88,654 28,700 Jul 29, 2022, 04:18 PM
Reich Siegfried EVP & Chief Scientific Officer Feb 09, 2022 Sale $36.30 397 14,411 3,448 Feb 11, 2022, 06:10 PM
Partridge Andrew John EVP & Chief Commercial Officer Feb 09, 2022 Sale $36.30 221 8,022 22,078 Feb 11, 2022, 06:09 PM
North Annette EVP & General Counsel Feb 09, 2022 Sale $36.30 669 24,285 11,696 Feb 11, 2022, 06:09 PM
Hirmand Mohammad EVP & Chief Medical Officer Feb 09, 2022 Sale $36.30 669 24,285 6,838 Feb 11, 2022, 06:08 PM
Countouriotis Athena President & CEO Feb 09, 2022 Sale $36.30 2,971 107,847 47,930 Feb 11, 2022, 06:07 PM
North Annette EVP, General Counsel & Secty. Aug 30, 2021 Option Exercise $17.00 10,000 170,000 22,365 Aug 31, 2021, 05:26 PM
North Annette EVP, General Counsel & Secty. Aug 30, 2021 Sale $80.00 10,000 800,000 12,365 Aug 31, 2021, 05:26 PM
Partridge Andrew John EVP & Chief Commercial Officer Jul 14, 2021 Sale $74.90 1,869 139,988 21,767 Jul 15, 2021, 05:53 PM
Alles Mark J Director Jun 21, 2021 Buy $81.34 2,000 162,680 2,000 Jun 21, 2021, 09:14 PM
Baker Brian Lee SVP of Finance and Admin. Mar 23, 2021 Option Exercise $4.67 28,435 132,906 32,551 Mar 24, 2021, 09:54 PM
Baker Brian Lee SVP of Finance and Admin. Mar 23, 2021 Sale $100.65 28,435 2,862,082 27,632 Mar 24, 2021, 09:54 PM
North Annette EVP, General Counsel & Secty. Mar 08, 2021 Option Exercise $17.00 20,000 340,000 26,483 Mar 09, 2021, 07:26 PM
North Annette EVP, General Counsel & Secty. Mar 08, 2021 Sale $109.80 20,000 2,195,939 25,983 Mar 09, 2021, 07:26 PM
Reich Siegfried EVP & Chief Scientific Officer Mar 04, 2021 Option Exercise $51.28 35,550 1,823,004 39,395 Mar 05, 2021, 08:56 PM
Reich Siegfried EVP & Chief Scientific Officer Mar 04, 2021 Sale $105.04 35,550 3,734,075 36,390 Mar 05, 2021, 08:56 PM
Countouriotis Athena President & CEO Feb 10, 2021 Option Exercise $3.20 25,392 81,254 75,587 Feb 11, 2021, 08:28 PM
Countouriotis Athena President & CEO Feb 09, 2021 Option Exercise $3.20 25,666 82,131 75,861 Feb 11, 2021, 08:28 PM
Countouriotis Athena President & CEO Feb 11, 2021 Option Exercise $3.20 8,942 28,614 59,137 Feb 11, 2021, 08:28 PM
Countouriotis Athena President & CEO Feb 10, 2021 Sale $136.31 25,392 3,461,116 74,562 Feb 11, 2021, 08:28 PM
Countouriotis Athena President & CEO Feb 09, 2021 Sale $138.68 25,666 3,559,475 69,661 Feb 11, 2021, 08:28 PM
Countouriotis Athena President & CEO Feb 11, 2021 Sale $137.38 8,942 1,228,446 54,818 Feb 11, 2021, 08:28 PM
North Annette EVP, General Counsel & Secty. Feb 02, 2021 Option Exercise $17.00 9,016 153,272 9,016 Feb 02, 2021, 09:50 PM
North Annette EVP, General Counsel & Secty. Feb 01, 2021 Option Exercise $17.00 15,984 271,728 15,984 Feb 02, 2021, 09:50 PM
North Annette EVP, General Counsel & Secty. Feb 01, 2021 Sale $123.65 15,984 1,976,374 14,354 Feb 02, 2021, 09:50 PM
North Annette EVP, General Counsel & Secty. Feb 02, 2021 Sale $129.88 9,016 1,170,989 8,616 Feb 02, 2021, 09:50 PM
Larson Yi EVP & Chief Financial Officer Feb 01, 2021 Option Exercise $54.03 15,702 848,379 18,406 Feb 02, 2021, 09:47 PM
Larson Yi EVP & Chief Financial Officer Feb 02, 2021 Option Exercise $54.03 14,298 772,521 17,002 Feb 02, 2021, 09:47 PM
Larson Yi EVP & Chief Financial Officer Feb 01, 2021 Sale $123.62 15,702 1,941,105 13,623 Feb 02, 2021, 09:47 PM
Larson Yi EVP & Chief Financial Officer Feb 02, 2021 Sale $130.14 14,298 1,860,813 16,002 Feb 02, 2021, 09:47 PM
Baker Brian Lee SVP of Finance and Admin. Jan 07, 2021 Option Exercise $4.67 28,438 132,918 32,246 Jan 08, 2021, 09:08 PM
Baker Brian Lee SVP of Finance and Admin. Jan 07, 2021 Sale $122.26 31,238 3,819,090 29,446 Jan 08, 2021, 09:08 PM
Hirmand Mohammad EVP and Chief Medical Officer Jan 04, 2021 Option Exercise $54.73 8,747 478,723 9,331 Jan 05, 2021, 09:03 PM
Hirmand Mohammad EVP and Chief Medical Officer Jan 05, 2021 Option Exercise $54.73 1,253 68,577 1,537 Jan 05, 2021, 09:03 PM
Hirmand Mohammad EVP and Chief Medical Officer Jan 04, 2021 Sale $120.49 9,047 1,090,046 9,031 Jan 05, 2021, 09:03 PM
Hirmand Mohammad EVP and Chief Medical Officer Jan 05, 2021 Sale $120.00 1,253 150,360 284 Jan 05, 2021, 09:03 PM
Cui Jingrong Jean Director Jun 09, 2020 Sale $65.81 9,500 625,194 549,471 Jun 10, 2020, 05:26 PM
Cui Jingrong Jean Director Jun 04, 2020 Sale $64.80 18,500 1,198,891 603,483 Jun 08, 2020, 08:26 PM
Cui Jingrong Jean Director Jun 08, 2020 Sale $63.45 18,500 1,173,888 566,511 Jun 08, 2020, 08:26 PM
Cui Jingrong Jean Director Jun 05, 2020 Sale $64.21 18,500 1,187,868 583,281 Jun 08, 2020, 08:26 PM
George Simeon Director May 21, 2020 Buy $60.00 83,333 4,999,980 2,253,660 May 26, 2020, 05:57 PM
Countouriotis Athena President & CEO May 21, 2020 Buy $60.00 4,166 249,960 26,872 May 26, 2020, 05:55 PM
GLAXOSMITHKLINE PLC Director May 21, 2020 Buy $60.00 83,333 4,999,980 2,253,660 May 26, 2020, 04:17 PM
Cui Jingrong Jean Director May 20, 2020 Sale $60.15 7,000 421,045 618,883 May 21, 2020, 07:05 PM
Cui Jingrong Jean Director May 19, 2020 Sale $57.73 7,000 404,108 625,183 May 21, 2020, 07:05 PM
Cui Jingrong Jean Director May 21, 2020 Sale $59.65 7,000 417,550 605,483 May 21, 2020, 07:05 PM
Cui Jingrong Jean Director May 08, 2020 Sale $53.86 11,500 619,351 637,153 May 12, 2020, 08:09 PM
Cui Jingrong Jean Director May 07, 2020 Sale $52.86 18,500 977,886 651,077 May 07, 2020, 06:52 PM
Cui Jingrong Jean Director May 06, 2020 Sale $52.94 18,500 979,323 668,811 May 07, 2020, 06:52 PM
Cui Jingrong Jean Director May 05, 2020 Sale $54.02 18,500 999,426 689,385 May 07, 2020, 06:52 PM
Cui Jingrong Jean Director Apr 24, 2020 Sale $51.01 7,000 357,090 697,170 Apr 24, 2020, 08:20 PM
Cui Jingrong Jean Director Apr 23, 2020 Sale $51.92 7,000 363,408 704,183 Apr 24, 2020, 08:20 PM
Cui Jingrong Jean Director Apr 22, 2020 Sale $51.78 7,000 362,481 708,683 Apr 24, 2020, 08:20 PM
Cui Jingrong Jean Director Apr 13, 2020 Sale $50.05 708 35,438 714,891 Apr 13, 2020, 07:16 PM
Cui Jingrong Jean Director Apr 09, 2020 Sale $47.45 11,500 545,648 720,609 Apr 13, 2020, 07:16 PM
Cui Jingrong Jean Director Apr 08, 2020 Sale $46.25 18,500 855,604 738,797 Apr 08, 2020, 07:21 PM
Cui Jingrong Jean Director Apr 07, 2020 Sale $44.86 18,500 829,998 759,091 Apr 08, 2020, 07:21 PM
Cui Jingrong Jean Director Apr 06, 2020 Sale $43.51 18,500 804,874 780,991 Apr 08, 2020, 07:21 PM
Cui Jingrong Jean Director Mar 26, 2020 Sale $46.03 11,500 529,372 786,991 Mar 27, 2020, 06:27 PM
Cui Jingrong Jean Director Mar 24, 2020 Sale $41.95 7,000 293,655 817,083 Mar 25, 2020, 06:47 PM
Cui Jingrong Jean Director Mar 23, 2020 Sale $38.39 7,000 268,706 824,483 Mar 25, 2020, 06:47 PM
Cui Jingrong Jean Director Mar 25, 2020 Sale $45.42 17,792 808,090 809,283 Mar 25, 2020, 06:47 PM
Cui Jingrong Jean Director Mar 12, 2020 Sale $36.08 7,000 252,528 829,783 Mar 12, 2020, 08:40 PM
Cui Jingrong Jean Director Mar 11, 2020 Sale $41.20 18,500 762,202 846,183 Mar 12, 2020, 08:40 PM
Cui Jingrong Jean Director Mar 10, 2020 Sale $42.28 18,500 782,113 862,283 Mar 12, 2020, 08:40 PM
Cui Jingrong Jean Director Feb 26, 2020 Sale $51.43 7,000 360,014 871,983 Feb 26, 2020, 08:20 PM
Cui Jingrong Jean Director Feb 25, 2020 Sale $51.35 7,000 359,478 879,858 Feb 26, 2020, 08:20 PM
Cui Jingrong Jean Director Feb 24, 2020 Sale $53.70 7,000 375,930 884,383 Feb 26, 2020, 08:20 PM
Cui Jingrong Jean Director Dec 27, 2019 Option Exercise $4.71 38,080 179,456 873,519 Feb 26, 2020, 08:18 PM
Cui Jingrong Jean Director Jun 27, 2019 Option Exercise $5.12 54,220 277,606 835,439 Feb 26, 2020, 08:18 PM
Cui Jingrong Jean Director Dec 30, 2019 Option Exercise $5.12 16,864 86,344 890,383 Feb 26, 2020, 08:18 PM
Cui Jingrong Jean Director Feb 13, 2020 Sale $61.84 11,500 711,137 792,519 Feb 14, 2020, 04:22 PM
Cui Jingrong Jean Director Feb 12, 2020 Sale $65.92 18,500 1,219,594 805,419 Feb 12, 2020, 07:31 PM
Cui Jingrong Jean Director Feb 11, 2020 Sale $63.23 18,500 1,169,667 815,469 Feb 12, 2020, 07:31 PM
Cui Jingrong Jean Director Feb 10, 2020 Sale $62.94 18,500 1,164,482 838,968 Feb 12, 2020, 07:31 PM
Cui Jingrong Jean Chief Scientific Officer Jan 28, 2020 Sale $58.36 7,000 408,529 858,151 Jan 29, 2020, 07:37 PM
Cui Jingrong Jean Chief Scientific Officer Jan 27, 2020 Sale $57.66 7,000 403,652 867,620 Jan 29, 2020, 07:37 PM
Cui Jingrong Jean Chief Scientific Officer Jan 29, 2020 Sale $58.73 7,000 411,104 851,820 Jan 29, 2020, 07:37 PM
Cui Jingrong Jean Chief Scientific Officer Jan 15, 2020 Sale $53.12 11,500 610,853 870,819 Jan 17, 2020, 05:10 PM
Cui Jingrong Jean Chief Scientific Officer Jan 14, 2020 Sale $53.56 18,500 990,811 895,829 Jan 14, 2020, 07:17 PM
Cui Jingrong Jean Chief Scientific Officer Jan 13, 2020 Sale $52.87 18,500 978,073 909,813 Jan 14, 2020, 07:17 PM
Cui Jingrong Jean Chief Scientific Officer Jan 10, 2020 Sale $57.68 18,500 1,067,161 935,919 Jan 14, 2020, 07:17 PM
Countouriotis Athena President & CEO Dec 10, 2019 Option Exercise $31.13 706 21,976 22,706 Jan 08, 2020, 04:24 PM
Baker Brian Lee VP of Finance and Admin. Dec 10, 2019 Option Exercise $31.13 216 6,723 3,016 Jan 08, 2020, 04:12 PM
Cui Jingrong Jean Chief Scientific Officer Dec 20, 2019 Sale $63.40 11,500 729,150 946,319 Dec 20, 2019, 06:29 PM
Cui Jingrong Jean Chief Scientific Officer Dec 19, 2019 Sale $61.09 18,500 1,130,257 964,819 Dec 20, 2019, 06:29 PM
Cui Jingrong Jean Chief Scientific Officer Dec 18, 2019 Sale $59.20 18,500 1,095,170 980,989 Dec 20, 2019, 06:29 PM
Cui Jingrong Jean Chief Scientific Officer Dec 17, 2019 Sale $61.32 18,500 1,134,374 999,619 Dec 17, 2019, 09:09 PM
Cui Jingrong Jean Chief Scientific Officer Dec 16, 2019 Sale $58.35 11,500 671,077 1,014,119 Dec 17, 2019, 09:09 PM
Cui Jingrong Jean Chief Scientific Officer Dec 13, 2019 Sale $55.75 11,500 641,169 1,019,119 Dec 17, 2019, 09:09 PM
Cui Jingrong Jean Chief Scientific Officer Dec 10, 2019 Sale $54.58 11,500 627,631 1,058,019 Dec 12, 2019, 07:54 PM
Cui Jingrong Jean Chief Scientific Officer Dec 12, 2019 Sale $54.11 11,500 622,291 1,037,219 Dec 12, 2019, 07:54 PM
Cui Jingrong Jean Chief Scientific Officer Dec 11, 2019 Sale $52.94 11,500 608,787 1,040,291 Dec 12, 2019, 07:54 PM
Cui Jingrong Jean Chief Scientific Officer Dec 09, 2019 Sale $55.32 11,500 636,229 1,069,219 Dec 09, 2019, 08:44 PM
Cui Jingrong Jean Chief Scientific Officer Dec 06, 2019 Sale $50.77 50,890 2,583,588 1,086,482 Dec 09, 2019, 08:44 PM
Cui Jingrong Jean Chief Scientific Officer Dec 05, 2019 Sale $51.95 56,110 2,914,936 1,157,939 Dec 09, 2019, 08:44 PM
GLAXOSMITHKLINE PLC Director Sep 10, 2019 Buy $45.00 177,777 7,999,965 2,170,327 Sep 12, 2019, 04:18 PM
George Simeon Director Sep 10, 2019 Buy $45.00 177,777 7,999,965 2,170,327 Sep 11, 2019, 06:42 PM
Larson Yi EVP & Chief Financial Officer Sep 10, 2019 Buy $45.00 2,222 99,990 2,222 Sep 11, 2019, 04:16 PM
Countouriotis Athena President & CEO Sep 10, 2019 Buy $45.00 10,000 450,000 22,000 Sep 11, 2019, 04:15 PM
Cormorant Asset Management, LP 10% Owner May 14, 2019 Option Exercise $2.19 23,268 51,062 3,122,367 May 16, 2019, 04:15 PM
Cormorant Asset Management, LP 10% Owner Apr 22, 2019 Buy $18.00 400,000 7,200,000 3,099,099 Apr 25, 2019, 04:08 PM
GLAXOSMITHKLINE PLC Director Apr 22, 2019 Buy $18.00 325,000 5,850,000 1,992,550 Apr 24, 2019, 07:28 PM
ORBIMED ADVISORS LLC Director Apr 22, 2019 Buy $18.00 360,000 6,480,000 2,027,550 Apr 24, 2019, 06:16 PM
Lu Hongbo Director Apr 22, 2019 Buy $18.00 60,000 1,080,000 1,727,550 Apr 24, 2019, 06:11 PM
GORDON CARL L Director Apr 22, 2019 Buy $18.00 360,000 6,480,000 2,027,550 Apr 24, 2019, 06:07 PM
George Simeon Director Apr 22, 2019 Buy $18.00 325,000 5,850,000 1,992,550 Apr 24, 2019, 06:04 PM
Baker Brian Lee VP of Finance and Admin. Apr 22, 2019 Buy $18.00 2,800 50,400 2,800 Apr 24, 2019, 06:00 PM
Countouriotis Athena President & CEO Apr 22, 2019 Buy $18.00 12,000 216,000 12,000 Apr 24, 2019, 05:55 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
George Simeon Director 08/17/2022 171,278,160
Alles Mark J Director 08/17/2022 152,000
TOMBESI PAOLO EVP & Chief Financial Officer 08/17/2022 2,263,128
Hirmand Mohammad EVP and Chief Medical Officer 08/17/2022 3,137,584
Countouriotis Athena President & CEO 08/17/2022 8,432,884
TOMBESI PAOLO EVP & Chief Financial Officer 07/27/2022 88,654
Reich Siegfried EVP & Chief Scientific Officer 02/09/2022 14,411
Partridge Andrew John EVP & Chief Commercial Officer 02/09/2022 8,022
North Annette EVP & General Counsel 02/09/2022 24,285
Hirmand Mohammad EVP & Chief Medical Officer 02/09/2022 24,285
Countouriotis Athena President & CEO 02/09/2022 107,847
North Annette EVP, General Counsel & Secty. 08/30/2021 170,000
North Annette EVP, General Counsel & Secty. 08/30/2021 800,000
Partridge Andrew John EVP & Chief Commercial Officer 07/14/2021 139,988
Alles Mark J Director 06/21/2021 162,680
Baker Brian Lee SVP of Finance and Admin. 03/23/2021 132,906
Baker Brian Lee SVP of Finance and Admin. 03/23/2021 2,862,082
North Annette EVP, General Counsel & Secty. 03/08/2021 340,000
North Annette EVP, General Counsel & Secty. 03/08/2021 2,195,939
Reich Siegfried EVP & Chief Scientific Officer 03/04/2021 1,823,004
Reich Siegfried EVP & Chief Scientific Officer 03/04/2021 3,734,075
Countouriotis Athena President & CEO 02/10/2021 81,254
Countouriotis Athena President & CEO 02/09/2021 82,131
Countouriotis Athena President & CEO 02/11/2021 28,614
Countouriotis Athena President & CEO 02/10/2021 3,461,116
Countouriotis Athena President & CEO 02/09/2021 3,559,475
Countouriotis Athena President & CEO 02/11/2021 1,228,446
North Annette EVP, General Counsel & Secty. 02/02/2021 153,272
North Annette EVP, General Counsel & Secty. 02/01/2021 271,728
North Annette EVP, General Counsel & Secty. 02/01/2021 1,976,374
North Annette EVP, General Counsel & Secty. 02/02/2021 1,170,989
Larson Yi EVP & Chief Financial Officer 02/01/2021 848,379
Larson Yi EVP & Chief Financial Officer 02/02/2021 772,521
Larson Yi EVP & Chief Financial Officer 02/01/2021 1,941,105
Larson Yi EVP & Chief Financial Officer 02/02/2021 1,860,813
Baker Brian Lee SVP of Finance and Admin. 01/07/2021 132,918
Baker Brian Lee SVP of Finance and Admin. 01/07/2021 3,819,090
Hirmand Mohammad EVP and Chief Medical Officer 01/04/2021 478,723
Hirmand Mohammad EVP and Chief Medical Officer 01/05/2021 68,577
Hirmand Mohammad EVP and Chief Medical Officer 01/04/2021 1,090,046
Hirmand Mohammad EVP and Chief Medical Officer 01/05/2021 150,360
Cui Jingrong Jean Director 06/09/2020 625,194
Cui Jingrong Jean Director 06/04/2020 1,198,891
Cui Jingrong Jean Director 06/08/2020 1,173,888
Cui Jingrong Jean Director 06/05/2020 1,187,868
George Simeon Director 05/21/2020 4,999,980
Countouriotis Athena President & CEO 05/21/2020 249,960
GLAXOSMITHKLINE PLC Director 05/21/2020 4,999,980
Cui Jingrong Jean Director 05/20/2020 421,045
Cui Jingrong Jean Director 05/19/2020 404,108
Cui Jingrong Jean Director 05/21/2020 417,550
Cui Jingrong Jean Director 05/08/2020 619,351
Cui Jingrong Jean Director 05/07/2020 977,886
Cui Jingrong Jean Director 05/06/2020 979,323
Cui Jingrong Jean Director 05/05/2020 999,426
Cui Jingrong Jean Director 04/24/2020 357,090
Cui Jingrong Jean Director 04/23/2020 363,408
Cui Jingrong Jean Director 04/22/2020 362,481
Cui Jingrong Jean Director 04/13/2020 35,438
Cui Jingrong Jean Director 04/09/2020 545,648
Cui Jingrong Jean Director 04/08/2020 855,604
Cui Jingrong Jean Director 04/07/2020 829,998
Cui Jingrong Jean Director 04/06/2020 804,874
Cui Jingrong Jean Director 03/26/2020 529,372
Cui Jingrong Jean Director 03/24/2020 293,655
Cui Jingrong Jean Director 03/23/2020 268,706
Cui Jingrong Jean Director 03/25/2020 808,090
Cui Jingrong Jean Director 03/12/2020 252,528
Cui Jingrong Jean Director 03/11/2020 762,202
Cui Jingrong Jean Director 03/10/2020 782,113
Cui Jingrong Jean Director 02/26/2020 360,014
Cui Jingrong Jean Director 02/25/2020 359,478
Cui Jingrong Jean Director 02/24/2020 375,930
Cui Jingrong Jean Director 12/27/2019 179,456
Cui Jingrong Jean Director 06/27/2019 277,606
Cui Jingrong Jean Director 12/30/2019 86,344
Cui Jingrong Jean Director 02/13/2020 711,137
Cui Jingrong Jean Director 02/12/2020 1,219,594
Cui Jingrong Jean Director 02/11/2020 1,169,667
Cui Jingrong Jean Director 02/10/2020 1,164,482
Cui Jingrong Jean Chief Scientific Officer 01/28/2020 408,529
Cui Jingrong Jean Chief Scientific Officer 01/27/2020 403,652
Cui Jingrong Jean Chief Scientific Officer 01/29/2020 411,104
Cui Jingrong Jean Chief Scientific Officer 01/15/2020 610,853
Cui Jingrong Jean Chief Scientific Officer 01/14/2020 990,811
Cui Jingrong Jean Chief Scientific Officer 01/13/2020 978,073
Cui Jingrong Jean Chief Scientific Officer 01/10/2020 1,067,161
Countouriotis Athena President & CEO 12/10/2019 21,976
Baker Brian Lee VP of Finance and Admin. 12/10/2019 6,723
Cui Jingrong Jean Chief Scientific Officer 12/20/2019 729,150
Cui Jingrong Jean Chief Scientific Officer 12/19/2019 1,130,257
Cui Jingrong Jean Chief Scientific Officer 12/18/2019 1,095,170
Cui Jingrong Jean Chief Scientific Officer 12/17/2019 1,134,374
Cui Jingrong Jean Chief Scientific Officer 12/16/2019 671,077
Cui Jingrong Jean Chief Scientific Officer 12/13/2019 641,169
Cui Jingrong Jean Chief Scientific Officer 12/10/2019 627,631
Cui Jingrong Jean Chief Scientific Officer 12/12/2019 622,291
Cui Jingrong Jean Chief Scientific Officer 12/11/2019 608,787
Cui Jingrong Jean Chief Scientific Officer 12/09/2019 636,229
Cui Jingrong Jean Chief Scientific Officer 12/06/2019 2,583,588
Cui Jingrong Jean Chief Scientific Officer 12/05/2019 2,914,936
GLAXOSMITHKLINE PLC Director 09/10/2019 7,999,965
George Simeon Director 09/10/2019 7,999,965
Larson Yi EVP & Chief Financial Officer 09/10/2019 99,990
Countouriotis Athena President & CEO 09/10/2019 450,000
Cormorant Asset Management, LP 10% Owner 05/14/2019 51,062
Cormorant Asset Management, LP 10% Owner 04/22/2019 7,200,000
GLAXOSMITHKLINE PLC Director 04/22/2019 5,850,000
ORBIMED ADVISORS LLC Director 04/22/2019 6,480,000
Lu Hongbo Director 04/22/2019 1,080,000
GORDON CARL L Director 04/22/2019 6,480,000
George Simeon Director 04/22/2019 5,850,000
Baker Brian Lee VP of Finance and Admin. 04/22/2019 50,400
Countouriotis Athena President & CEO 04/22/2019 216,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
06/30/2022
03/31/2022
0.09%
1Q
06/30/2022
12/31/2021
0.80%
2Q
06/30/2022
09/30/2021
0.96%
3Q
06/30/2022
06/30/2021
1.21%
4Q
06/30/2022
03/31/2021
1.51%
5Q
06/30/2022
12/31/2020
21.58%
6Q
06/30/2022
09/30/2020
27.61%
7Q
06/30/2022
06/30/2020
33.27%
8Q
06/30/2022
03/31/2020
38.25%
9Q
Load More

Period of Report: 06/30/2022

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
03/31/2022
0.09%
1Q
12/31/2021
0.80%
2Q
09/30/2021
0.96%
3Q
06/30/2021
1.21%
4Q
03/31/2021
1.51%
5Q
12/31/2020
21.58%
6Q
09/30/2020
27.61%
7Q
06/30/2020
33.27%
8Q
03/31/2020
38.25%
9Q
Load More